News | Proton Therapy | May 23, 2017

First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center

PBS technology is part of latest upgrade to French center’s Proteus Plus proton therapy system

First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center

May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at the Institut Curie in Orsay, France.
 
Since its opening in 1991, more than 8,000 patients have been treated at the Institute Curie Proton Therapy Center. During this time, the center has gradually upgraded its equipment to increase the number of indications that can be treated. Today, around fifty patients are treated every day in the three rooms available. The rooms include one gantry, one fixed beam and an eye line.
 
PBS is the latest addition to the IBA Proteus Plus solution in operation in Orsay. PBS enables the clinician to deliver intensity modulated proton therapy by accurately targeting the tumor with controlled dose intensity and precise spatial distribution. To date, more than 200,000 fractions have been delivered with IBA pencil beam scanning equipment.
 
Remi Dendale, M.D., deputy director of the Institute Curie Proton Therapy Center, commented, “We are very happy to upgrade our equipment with the latest technology available. This enables us to offer proton therapy to more patients by broadening the list of indications we can treat. Thanks to the excellent collaboration with IBA, our team has been able to implement this new feature with zero impact on our clinical operations.”
 
For more information: www.iba-worldwide.com

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init